Trade Summary

3 days ago, Edwards Carladenise Armbrister, serving as Dir at Clover Health Investments, Corp. /De (CLOV), sold 67,160 shares at $3.42 per share, for a total transaction value of $229,687.00. Following this transaction, Edwards Carladenise Armbrister now holds 285,432 shares of CLOV.

This sale represents a 19.00% decrease in Edwards Carladenise Armbrister's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 18, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 19, 2026 at 5:32 PM ET, 1 day after the trade was made.

Clover Health Investments, Corp. /De operates in the HEALTHCARE sector, specifically within the HEALTHCARE PLANS industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.